Why The PhytoTech Medical Limited Share Price Fell Today

By ,

What Happened to the PhytoTech Medical Share Price?

PhytoTech Medical Limited [ASX:PYL] is a newly listed Australian company. It is developing medical cannabis for the US, Canada, Israel, Europe, Australia and New Zealand.

PhytoTech Medical are developing, manufacturing and marketing a novel delivery system of medical cannabis. PhytoTech plan to bring to market a flexible mucosdhesive adhesive patch that will release the pain killing properties of marijuana in a controlled manner.

PhytoTech medical have the exclusive license for this patented product by Yissum Research Project.

Patients can take medical cannabis in a variety of methods including vaporising and smoking dried buds, eating extracts or capsules, or oral spray.

The share price closed 12.84% lower on Friday.

Why Did This Happen to PhytoTech Medical Shares?

This company has caught the market by surprise.

However the share price is volatile. Yesterday the stock closed up 9% higher to 54 cents, and today’s it’s taken a hammering.

Only six trading days in, PhytoTech Medical is already trading at more than double its 20 cent initial public offering price.

Within two days of listing, PYL shares soared to a high of 92c, before falling back to today’s closing price of 47.5 cents.

The company listed on the ASX on 22 January 2015.

What Now for PhytoTech Medical?

Already this is a tricky company to analyse.

I hit up our resident small cap expert Tim Dohrmann of Australian Small-Cap Investigator for a suggestion on what the unexpected share price activity could mean.

Tim tells me, ‘It’s one of two things. There’s either some funny business going on…or the more likely scenario is that no one actually knows what this company is worth or how to value it just yet.’

A progressive company that campaigns globally for legal use of medical marijuana may sound like an exciting investment to be part of.

However the volatility of the stock suggests that it may be too early to invest in it for now.

Shae Smith
Editor, Money Weekend

Join Money Morning on Google+

About Shae Russell

Since starting out in the financial markets over a decade ago, Shae has extensive experience across various aspects of the industry. Shae cut her teeth in the derivatives industry, teaching clients basic trading techniques with technical analysis.

Joining Fat Tail Investment Research eight years ago, Shae has worked across a…

Pure Hydrogen Shares Rise 11% on Investor Update

Aussie hydrogen stock Pure Hydrogen [ASX:PH2] exited a trading halt on Thursday following ASX queries about its June investor presentation.

Bubs [ASX:BUB] Slides 8% on More US Supply Deal News

Infant formula producer Bubs Australia [ASX:BUB] provided the market with another update regarding its recent emergency supply deal with the US.

Renascor (ASX:RNU) Shares Rise on Highest-Grade Graphite to Date

South Australian graphite stock Renascor Resources [ASX:RNU] released drilling assay results showing its ‘highest grade graphite to date’.

Talga [ASX:TLG] Shares Rise on Vittangi Graphite Drilling Update

Graphite and battery materials stock Talga Group Ltd [ASX:TLG] updated the market on new drill results at its Sweden graphite project.

Bubs Announces $68 Million Capital Raise

[ASX:BUB] is rattling the can to raise $68 million to support ‘growth opportunities.’

Bubs (ASX:BUB) Shares up on US Supply Deal Update

Infant nutrition producer Bubs Australia [ASX:BUB] came out with another supplier update today, signing supply agreements with two more US retailers.